¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacional

Background: The role of staging studies in patients with prostate cancer (PCa) is a topic of discussion. Aim: To evaluate the usefulness of imaging studies in patients with prostate cancer. Material and Methods: We reviewed the pathology service records to identify patients with prostate cancer diag...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martínez M,Nagel, Calvo,Carlos, Ibarra,Álvaro, Ramos,Christian, Zambrano,Norman
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2017
Materias:	Neoplasm Metastasis Neoplasm Staging Prostatic Neoplasms Risk
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000500004
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872017000500004
record_format	dspace
spelling	oai:scielo:S0034-988720170005000042017-11-16¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacionalMartínez M,NagelCalvo,CarlosIbarra,ÁlvaroRamos,ChristianZambrano,Norman Neoplasm Metastasis Neoplasm Staging Prostatic Neoplasms Risk Background: The role of staging studies in patients with prostate cancer (PCa) is a topic of discussion. Aim: To evaluate the usefulness of imaging studies in patients with prostate cancer. Material and Methods: We reviewed the pathology service records to identify patients with prostate cancer diagnosed between 2003 and 2013. We reviewed the electronic medical records of those patients identified as having a prostate cancer. Patients were grouped according Damicos classification of cancer dissemination risk. We analized the frequency of imaging studies requested and their efficacy to detect metastases in each risk group. Results: We identified 241 patients with a mean age of 67 years. Fifty two percent of patients were classified as low-risk, 32% as intermediate-risk and 16% as high risk. At least one imaging study was requested to 64% of patients (49, 78 and 87% of patients with low, intermediate and high risk respectively). Among the 155 patients in whom an imaging study was requested, no metastases were found in the low risk group. On the other hand, dissemination was found in 7% of the intermediate-risk group and 62% of the high-risk group. Conclusions: Half of patients with prostate cancer were classified as low risk. In half of this group of low risk patients, staging studies were requested and the probability of detecting metastases was low or nil. The odds of detecting metastases increased in higher risk groups.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.145 n.5 20172017-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000500004es10.4067/S0034-98872017000500004
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Neoplasm Metastasis Neoplasm Staging Prostatic Neoplasms Risk
spellingShingle	Neoplasm Metastasis Neoplasm Staging Prostatic Neoplasms Risk Martínez M,Nagel Calvo,Carlos Ibarra,Álvaro Ramos,Christian Zambrano,Norman ¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacional
description	Background: The role of staging studies in patients with prostate cancer (PCa) is a topic of discussion. Aim: To evaluate the usefulness of imaging studies in patients with prostate cancer. Material and Methods: We reviewed the pathology service records to identify patients with prostate cancer diagnosed between 2003 and 2013. We reviewed the electronic medical records of those patients identified as having a prostate cancer. Patients were grouped according Damicos classification of cancer dissemination risk. We analized the frequency of imaging studies requested and their efficacy to detect metastases in each risk group. Results: We identified 241 patients with a mean age of 67 years. Fifty two percent of patients were classified as low-risk, 32% as intermediate-risk and 16% as high risk. At least one imaging study was requested to 64% of patients (49, 78 and 87% of patients with low, intermediate and high risk respectively). Among the 155 patients in whom an imaging study was requested, no metastases were found in the low risk group. On the other hand, dissemination was found in 7% of the intermediate-risk group and 62% of the high-risk group. Conclusions: Half of patients with prostate cancer were classified as low risk. In half of this group of low risk patients, staging studies were requested and the probability of detecting metastases was low or nil. The odds of detecting metastases increased in higher risk groups.
author	Martínez M,Nagel Calvo,Carlos Ibarra,Álvaro Ramos,Christian Zambrano,Norman
author_facet	Martínez M,Nagel Calvo,Carlos Ibarra,Álvaro Ramos,Christian Zambrano,Norman
author_sort	Martínez M,Nagel
title	¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacional
title_short	¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacional
title_full	¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacional
title_fullStr	¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacional
title_full_unstemmed	¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacional
title_sort	¿es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: experiencia de un centro clínico nacional
publisher	Sociedad Médica de Santiago
publishDate	2017
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000500004
work_keys_str_mv	AT martinezmnagel esnecesariorealizarunestudiodeetapificacionentodoslospacientesconcancerdeprostataexperienciadeuncentrocliniconacional AT calvocarlos esnecesariorealizarunestudiodeetapificacionentodoslospacientesconcancerdeprostataexperienciadeuncentrocliniconacional AT ibarraalvaro esnecesariorealizarunestudiodeetapificacionentodoslospacientesconcancerdeprostataexperienciadeuncentrocliniconacional AT ramoschristian esnecesariorealizarunestudiodeetapificacionentodoslospacientesconcancerdeprostataexperienciadeuncentrocliniconacional AT zambranonorman esnecesariorealizarunestudiodeetapificacionentodoslospacientesconcancerdeprostataexperienciadeuncentrocliniconacional
_version_	1718436942729707520

¿Es necesario realizar un estudio de etapificación en todos los pacientes con cáncer de próstata?: Experiencia de un centro clínico nacional

Ejemplares similares